ResMed (RMD) Reports In-Line Q1 EPS, Beats on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $209.63 +4.24%
Revenue Growth %: +13.1%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
CRMT, More
Revenue Growth %: +13.1%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.66, in-line with the analyst estimate of $0.66. Revenue for the quarter came in at $523.7 million versus the consensus estimate of $505.61 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
